Search Publications


Molecular mechanisms involved with influenza A nanovaccine immunogenicity in pigs. Author(s): IBELLI, A. M. G.; PEIXOTO, J. de O.; FERNANDES, L. T.; HAACH, V.; GAVA, D.; BASTOS, A. P. A.; FONSECA, F. M. da; MORES, M. A. Z.; CANTAO, M. E.; SCHAEFER, R.; LEDUR, M. C. Abstract: Influenza A virus (IAV) is one of the most important primary agents in porcine respiratory disease complex (PRDC). The gene expression profile was evaluated by RNA-Seq analysis in mediastina... ... Repository: BDPA Publication year: 2022
Transcriptomic profiling shows the induction of humoral and cellular response-related genes in pigs following vaccination with an Influenza A nanovaccine. Author(s): IBELLI, A. M. G.; FERNANDES, L.; HAACH, V.; GAVA, D.; BASTOS, A. P. A.; OKINO, C. H.; PEIXOTO, J. de O.; FONSECA, F. M. da; MORES, M. A. Z.; CANTAO, M. E.; SCHAEFER, R.; LEDUR, M. C. Repository: BDPA Publication year: 2023
Immunological profile of mice immunized with a polyvalent virosome-based influenza vaccine. Author(s): FONSECA, F. M. da; HAACH, V.; BELLAVER, F. V.; BOMBASSARO, G.; GAVA, D.; SILVA, L. P. da; BARON, L. F.; SIMONELLY, M.; CARVALHO, W. A.; SCHAEFER, R.; BASTOS, A. P. A. Background - Influenza A virus (IAV) causes respiratory disease in pigs and is a major concern for public health. Vaccination of pigs is the most successful measure to mitigate the impact of the disea... ... Repository: BDPA Publication year: 2023

Showing 3 results.

Portal Embrapa